To understand mechanistically how CARM1 might be regulating NGFR signaling we used an antibody and mass spectrometry approach to define the known CARM1 substrates in NSC11 GSCs—a method previously used to identify CARM1 substrates in human breast cancer cells [21]. Here, CARM1 is linked to breast carcinoma.